Analysis of Desloratadin Shim-pack GIST C18)

Significance of the Topic

Desloratadine is a second-generation H1 antihistamine widely used for the treatment of allergic conditions. Precise quantification and impurity profiling are essential to guarantee drug safety, efficacy, and compliance with regulatory standards in pharmaceutical quality control.

Objectives and Study Overview

This work describes the development and validation of a reversed-phase liquid chromatography method to simultaneously determine desloratadine and its specified impurity B. The primary goal was to establish a robust, reproducible protocol suitable for routine analysis in quality assurance laboratories.

Methodology and Instrumentation

• Column: Shim-pack GIST C18, 150 mm × 4.6 mm I.D., 5 μm particle size
• Mobile Phase: A – 0.865 g sodium lauryl sulfonate + 0.5 mL trifluoroacetic acid in water (1 L); B – acetonitrile; ratio A : B = 57 : 43
• Flow Rate: 1.0 mL/min
• Column Temperature: 35 °C
• Injection Volume: 20 μL
• Detection: UV at 280 nm
• Sample Preparation: Weigh 20 mg desloratadine, dissolve in mobile phase, perform stepwise dilutions to final volume with mobile phase to achieve target concentration

Main Results and Discussion

The method achieved clear baseline separation of impurity B and desloratadine within a 35-minute run. The chromatogram displayed two well-resolved peaks with consistent retention times and acceptable peak symmetry. Recovery studies and repeat injections confirmed method precision, accuracy, and robustness against minor variations in operating conditions.

Benefits and Practical Applications

This reversed-phase HPLC approach offers a straightforward, cost-effective solution for purity assessment of desloratadine in raw materials and finished products. Its compatibility with common LC instrumentation and uncomplicated mobile phase composition makes it attractive for routine QC, R&D, and regulatory laboratories.

Future Trends and Opportunities

Emerging technologies such as ultra-high-performance liquid chromatography (UHPLC), gradient elution strategies, and LC–MS/MS detection can further enhance sensitivity, resolution, and throughput. Automation of sample preparation and adoption of greener reagents will support increased efficiency and environmental sustainability in pharmaceutical analytics.

Conclusion

The validated reversed-phase LC method provides reliable, precise, and reproducible analysis of desloratadine and its impurity B. Its ease of implementation and robust performance make it well suited for routine quality control and impurity profiling in pharmaceutical settings.